
Spartan Bioscience files for creditor protection, lays off nearly 70% of staff
Ottawa biotech firm says it is restructuring in the wake of a “higher-than-expected level of inconclusive results” from its rapid COVID-19 testing device.

Spartan Bioscience files for creditor protection, lays off nearly 70% of staff
Ottawa biotech firm says it is restructuring in the wake of a “higher-than-expected level of inconclusive results” from its rapid COVID-19 testing device.
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored


This holiday season, buy local and build up Ottawa
OBJ INSIDER HOLIDAY SAVINGS EVENT. See the full story.